Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
large
Revenue
2.4%
Debt
0%
Liquidity
46.9%
Revenue
Debt
Liquidity
2.4%
INR Crores
| Pharmaceutical Products | ₹1,205.64 |
| Sale of Services | ₹89.89 |
| Other Income | ₹2.23 |
INR Crores
INR Crores
| Interest Income | ₹32.57 |
INR Crores
| Revenue from Questionable Sources: | ₹0.00 |
| Revenue from Non Compliant Sources: | ₹32.57 |
| Total: | ₹32.57 |
| Total Revenue: | ₹1,330.33 |
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
₹32.57
₹1,330.33
= 2.4%
compliant
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
